The anticoagulation of calf thrombosis (ACT) project: results from the randomized controlled external pilot trial

Daniel Horner1, Kerstin Hogg2, Richard Body1

  • 1Emergency Department, The University of Manchester, Manchester, England.

Chest
|July 11, 2014
PubMed
Abstract

Insights

This pilot study found it feasible to research anticoagulation for isolated distal deep vein thrombosis (IDDVT). Anticoagulation may reduce serious VTE complications, warranting further investigation.

Area of Science:

  • Vascular Medicine
  • Thrombosis Research
  • Clinical Trial Design

Background:

  • Limited evidence exists on the clinical significance of isolated distal deep vein thrombosis (IDDVT).
  • International guidelines offer varying recommendations for IDDVT diagnosis and treatment.
  • The benefits of anticoagulation for IDDVT remain unquantified.

Purpose of the Study:

  • To assess the feasibility of conducting a randomized controlled trial for IDDVT.
  • To provide a primary outcome point estimate for a definitive study.
  • To evaluate the potential benefits of therapeutic anticoagulation in IDDVT patients.

Main Methods:

  • An open-label, external pilot randomized controlled trial was conducted.
  • Symptomatic, ambulatory patients with IDDVT were randomized to therapeutic anticoagulation or conservative management.
  • Patients underwent blinded duplex imaging and 3-month follow-up; intention-to-treat analysis was used.

Main Results:

  • Seventy of 93 eligible patients (88.6%) were recruited, with high follow-up rates.
  • The primary clinical outcome occurred in 11.4% of conservatively treated patients versus 0% in the anticoagulated group.
  • No major bleeding events were reported in either group.

Conclusions:

  • A definitive study on the value of therapeutic anticoagulation for IDDVT is feasible.
  • This study provides an estimated point for serious complications associated with a conservative approach.
  • Findings support further research into anticoagulation strategies for IDDVT.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.7K
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
466
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
746
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
413